Detalhe da pesquisa
1.
Systemic autoimmune myopathies: a prospective phase 4 controlled trial of an inactivated virus vaccine against SARS-CoV-2.
Rheumatology (Oxford)
; 61(8): 3351-3361, 2022 08 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-34664616
2.
Strong response after fourth dose of mRNA COVID-19 vaccine in autoimmune rheumatic diseases patients with poor response to inactivated vaccine.
Rheumatology (Oxford)
; 62(1): 480-485, 2022 12 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-35639644
3.
Association between physical activity and immunogenicity of an inactivated virus vaccine against SARS-CoV-2 in patients with autoimmune rheumatic diseases.
Brain Behav Immun
; 101: 49-56, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-34954325
4.
Immunogenicity, safety, and antiphospholipid antibodies after SARS-CoV-2 vaccine in patients with primary antiphospholipid syndrome.
Lupus
; 31(8): 974-984, 2022 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-35593174
5.
Anti-SARS-CoV-2 inactivated vaccine in patients with ANCA-associated vasculitis: Immunogenicity, safety, antibody decay and the booster dose.
Clinics (Sao Paulo)
; 78: 100150, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36529052
6.
Physical Activity: A Strategy to Improve Antibody Response to a SARS-CoV-2 Vaccine Booster Dose in Patients With Autoimmune Rheumatic Diseases.
J Phys Act Health
; 20(4): 311-316, 2023 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36870351
7.
No Associations Between Physical Activity and Immunogenicity in SARS-CoV-2 Seropositive Patients With Autoimmune Rheumatic Diseases Prior to and After Vaccination.
J Phys Act Health
; 20(10): 980-983, 2023 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37290768
8.
Interaction of TNFi and conventional synthetic DMARD in SARS-CoV-2 vaccine response in axial spondyloarthritis and psoriatic arthritis.
Joint Bone Spine
; 90(1): 105464, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36150668
9.
Safety and immunogenicity of CoronaVac in people living with HIV: a prospective cohort study.
Lancet HIV
; 9(5): e323-e331, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35338835
10.
Immunogenicity and safety of two doses of the CoronaVac SARS-CoV-2 vaccine in SARS-CoV-2 seropositive and seronegative patients with autoimmune rheumatic diseases in Brazil: a subgroup analysis of a phase 4 prospective study.
Lancet Rheumatol
; 4(2): e113-e124, 2022 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-34901885
11.
Effect of an exercise bout before the booster dose of an inactivated SARS-CoV-2 vaccine on immunogenicity in immunocompromised patients.
J Appl Physiol (1985)
; 132(3): 682-688, 2022 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35142560
12.
Immunogenicity decay and case incidence six months post Sinovac-CoronaVac vaccine in autoimmune rheumatic diseases patients.
Nat Commun
; 13(1): 5801, 2022 10 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36192386
13.
Immunogenicity and safety of the CoronaVac inactivated vaccine in patients with autoimmune rheumatic diseases: a phase 4 trial.
Nat Med
; 27(10): 1744-1751, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34331051
14.
Abatacept induced long-term non-progressive reduction in gamma-globulins and autoantibodies: dissociation from disease activity control.
Clin Rheumatol
; 39(6): 1747-1755, 2020 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-31927715
15.
Anti-SARS-CoV-2 inactivated vaccine in patients with ANCA-associated vasculitis: Immunogenicity, safety, antibody decay and the booster dose
Clinics
; 78: 100150, 2023. tab, graf
Artigo
em Inglês
|
LILACS-Express
| ID: biblio-1421262
16.
Discontinuing methotrexate to enhance vaccine response.
Nat Rev Rheumatol
; 18(9): 497-498, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35869395
17.
Withholding methotrexate after COVID-19 vaccination: different strategies, same results?
Lancet Rheumatol
; 4(12): e817, 2022 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-36447942